Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

MGI Tech Co., Ltd.

MGI Tech Co., Ltd. produces sequencing instruments, reagents, equipment and related products to support life science ... read more Featured Products: More products

Download Mobile App





MGI Tech Showcases World-First High-Throughput Automated Sample Transfer Processing System at MEDICA 2021

By LabMedica International staff writers
Posted on 17 Nov 2021

MGI Tech Co. More...

, Ltd. (Shenzhen, China) showcased some of its latest laboratory automation systems for sample transfer, sample extraction and library preparation, including the world’s first high-throughput automated sample transfer processing system, at MEDICA 2021.

MGI’s automation systems on display at the event included the MGISP-960, MGISP-NE384, MGISTP-7000 and MGISTP-3000 - all of which can be harnessed in the fight against the COVID-19 pandemic. MGISTP-7000 is a high-throughput automated sample transfer processing system that was specially designed for nucleic acid detection in the COVID-19 pandemic. The system integrates tube decapping, tube recapping, barcode identification, automated liquid transfer and negative pressure protection. With just a single click, the MGISTP-7000 can load original samples with caps and transfer up to 192 potential contagious samples from airtight sample tubes or plain tubes to 96-well microplates, with zero human contact during the process in 40 minutes. This first-of-its-kind automation system has already received CE marking and been rolled out in laboratories in Europe.

MGISTP-3000 is the benchtop version of the STP7000, offering automated sample transfer processing with tube decapping, tube recapping, barcode identification, automated liquid transfer and negative pressure protection for up to 96 samples. This compact desktop system is capable of processing 1,000 to 10,000 samples per day with just one click. MGISP-NE384 is a high-throughput automated nucleic acid extractor that adopts magnetic rod technology. Together with a nucleic acid extraction kit, MGISP-NE384 is able to extract and purify nucleic acid from 96/192/288/384 samples. HEPA filtration system and UV lamp ensure a safe working environment for nucleic acid extraction and lab technicians. MGISP-NE384 is particularly beneficial for labs looking to improve daily testing capacity for COVID-19. One single unit can process 10,000 samples per day, and the daily testing capacity of 10 units can reach up to 1 million if 10 samples are mixed in one tube.

MGISP-960 is a highly efficient, widely used automated sample preparation system equipped with comprehensive functions, economic and efficient operation and comprehensive protection in a truly open platform. A flexible, fully automated workstation with 96-channel pipette, which can be used for COVID sample extraction and PCR set-up. MGISP-960 has also validated plenty of library kits including WES, WGS, RNA and more. Meanwhile, the device's fully automatic operation design can realize unmanned processes and be customized according to the user's specific needs.

MGI has already combined the MGISP-960, MGISP-NE384 and MGISTP-7000 in a single automated, integrated container laboratory that significantly improves testing capacity for large-scale COVID-19 nucleic acid testing. The container is an integrated platform that automates the management of the entire testing process, from barcode identification to sample dispatch, nucleic acid extraction, fluorescence quantitative PCR testing, and report distribution. A game-changing system, MGI's container laboratory has already been embraced by companies across Europe.

Related Links:
MGI Tech Co., Ltd. 


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Portable Electronic Pipette
Mini 96
New
Gold Member
Hematology Analyzer
Medonic M32B
New
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Dormant tumor cells evade imaging tests and may later reactivate to spread metastatic breast cancer (Photo courtesy of David A. Litman/Shutterstock)

MRD Testing Can Identify Breast Cancer Survivors at Higher Risk of Recurrence

Breast cancer survival rates continue to improve, but recurrence remains incurable and affects around 30% of patients. Some subtypes, like triple negative and HER2+, relapse within years, while ER+ cancers... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.